Company: TAK
Filing Date: 2025-06-25
Form Type: 20-F
Source: 0001395064-25-000095
Chunk: 215

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-06-25
Form: 20-F
Item: Item 19
Chunk 215
---
Item 19. Exhibits

  Exhibit            Exhibit                                                                                                                                                                                               
  Exhibit 1.1        Articles of Incorporation of Takeda Pharmaceutical Company Limited (English Translation) (incorporated by reference to Exhibit 99.1 to the Current Report on Form 6-K of the registrant furnished...  
  Exhibit 1.2        Board of Directors Charter of Takeda Pharmaceutical Company Limited (English Translation) (incorporated by reference to Exhibit 1.2 to the Annual Report for the Fiscal Year Ended March 31, 2023...  
  Exhibit 1.3        Company Share Policy of Takeda Pharmaceutical Company Limited (English Translation) (incorporated by reference to Exhibit 1.3 to the Annual Report for the Fiscal Year Ended March 31, 2022 on Fo...  
  Exhibit 2.1        Form of Amended and Restated Deposit Agreement among the Takeda Pharmaceutical Company Limited, The Bank of New York Mellon, as Depositary, and all Owners and Holders from time to time of Ameri...  
  Exhibit 2.2        Description of the rights of each class of securities that is registered under Section 12 of the Exchange Act as of the end of the period covered by this report (incorporated by reference to Ex...  
  Exhibit 4.1+       Collaboration Agreement dated December 14, 2009 by and between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and Takeda Manufacturing U. S. A., Inc. (as successor in interest to Millennium Pharmac...  
  Exhibit 4.2+       Amendment to Collaboration Agreement dated November 7, 2022 by and between Seagen Inc. and Takeda Manufacturing U. S. A., Inc. (incorporated by reference to Exhibit 10.2 to the Annual Report of...  
  Exhibit 4.3        Takeda Pharmaceutical Company Limited Long - Term Incentive Plan (incorporated by reference to Exhibit 99.1 to the Registration Statement on Form S-8 of the registrant filed on June 25, 2020).      
  Exhibit 4.4+       Stock Purchase Agreement dated December 13, 2022 by and between Takeda Pharmaceuticals U. S. A., Inc. and Nimbus Therapeutics, LLC (incorporated by reference to Exhibit 4.4 to the Annual Report...  
  Exhibit 8.1        List of subsidiaries of Takeda